Quipt Home Medical Corp. (NASDAQ:QIPT) Sees Significant Growth in Short Interest

Quipt Home Medical Corp. (NASDAQ:QIPT) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,430,000 shares, a growth of 36.2% from the December 15th total of 1,050,000 shares. Approximately 3.7% of the shares of the company are short sold. Based on an average trading volume of 191,800 shares, the days-to-cover ratio is presently 7.5 days.

Quipt Home Medical Stock Performance

NASDAQ:QIPT traded up $0.09 during trading hours on Friday, reaching $3.02. The stock had a trading volume of 243,799 shares, compared to its average volume of 318,725. The stock has a market cap of $130.13 million, a P/E ratio of -20.13 and a beta of 0.56. The stock has a 50 day simple moving average of $2.72 and a 200 day simple moving average of $2.89. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.86 and a current ratio of 1.20. Quipt Home Medical has a 12-month low of $2.30 and a 12-month high of $4.99.

Quipt Home Medical (NASDAQ:QIPT) last announced its quarterly earnings data on Monday, December 16th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.08). Quipt Home Medical had a negative return on equity of 6.18% and a negative net margin of 2.66%. On average, research analysts forecast that Quipt Home Medical will post -0.15 EPS for the current fiscal year.

Insider Buying and Selling

In related news, VP Patrick Dennis Gamble purchased 17,000 shares of the firm’s stock in a transaction dated Thursday, December 26th. The stock was bought at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the purchase, the vice president now directly owns 40,057 shares in the company, valued at approximately $98,139.65. This trade represents a 73.73 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 4.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Quipt Home Medical

Several hedge funds and other institutional investors have recently modified their holdings of the business. Hsbc Holdings PLC grew its stake in Quipt Home Medical by 10.4% in the 2nd quarter. Hsbc Holdings PLC now owns 52,522 shares of the company’s stock valued at $165,000 after buying an additional 4,969 shares in the last quarter. State Street Corp grew its position in shares of Quipt Home Medical by 1.0% in the third quarter. State Street Corp now owns 621,388 shares of the company’s stock valued at $1,814,000 after purchasing an additional 6,317 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Quipt Home Medical by 21.0% during the 2nd quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock valued at $159,000 after purchasing an additional 8,541 shares during the period. Jane Street Group LLC lifted its holdings in Quipt Home Medical by 28.5% during the 3rd quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock worth $122,000 after purchasing an additional 9,290 shares in the last quarter. Finally, ProShare Advisors LLC bought a new position in Quipt Home Medical in the 2nd quarter worth about $35,000. Institutional investors own 42.85% of the company’s stock.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.